The striking diffusion and exciting perspectives of 177Lu in targeted radionuclide therapy (TRT) are primarily attributed to the following. The mean penetration range of β− particles
Technetium-99m is a radioactive tracer that is used in twenty million medical diagnostic procedures per year. At least 31 radiopharmaceuticals based on Tc-99m are used
Abstract Alpha particle-emitting isotopes are being investigated in radioimmunotherapeutic applications because of their unparalleled cytotoxicity when targeted to cancer and their relative lack
Abstract BACKGROUND: A remarkable therapeutic efficacy has been demonstrated with 225Ac-prostate-specific membrane antigen (PSMA)-617 in heavily pre-treated metastatic castration-resistant prostate cancer (mCRPC) patients.
Abstract Objective: Brachytherapy employing iodine-125 seeds is an established treatment for low-risk prostate cancers. Post-implant dosimetry (PID) is an important tool for identifying suboptimal
Abstract Background: This review provides a comprehensive summary of the production of 177Lu to meet expected future research and clinical demands. Availability of
Abstract Purpose of the Study: With rapid development in the field of nuclear medicine therapy, radiation safety of the personnel involved in synthesis
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies. Read more about our Privacy Policy